BioNexus Gene Lab Corp. Depreciation
BioNexus Gene Lab Corp. (BGLC) reported Depreciation of $56.36 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-14
- BioNexus Gene Lab Corp. depreciation for the quarter ending 2026-06-30 was $28.07K, a 0.95% increase year-over-year.
- BioNexus Gene Lab Corp. depreciation for the quarter ending 2026-03-31 was $28.29K, a 6.20% increase year-over-year.
- BioNexus Gene Lab Corp. depreciation for the quarter ending 2025-12-31 was $28.43K, a 3.79% decline year-over-year.
- BioNexus Gene Lab Corp. depreciation for the quarter ending 2025-09-30 was $29.00K, a 15.37% decline year-over-year.
- BioNexus Gene Lab Corp. depreciation for fiscal 2025 was $111.87K, a 7.40% increase from fiscal 2024.
- BioNexus Gene Lab Corp. depreciation for fiscal 2024 was $104.16K, a 25.11% increase from fiscal 2023.
- BioNexus Gene Lab Corp. depreciation for fiscal 2023 was $83.25K, a 8.94% decline from fiscal 2022.
- BioNexus Gene Lab Corp. depreciation for fiscal 2022 was $91.43K, a 0.16% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $56.36K 10-Q · filed 2026-08-14 | $84.79K derived: sum of 3 quarters · filed 2026-08-14 | $113.79K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $28.29K 10-Q · filed 2026-05-15 | $56.72K derived: sum of 2 quarters · filed 2026-05-15 | $85.72K derived: sum of 3 quarters · filed 2026-05-15 | $113.52K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $28.43K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | $57.43K derived: sum of 2 quarters · filed 2026-04-14 | $85.23K derived: sum of 3 quarters · filed 2026-08-14 | $111.87K 10-K · filed 2026-04-14 | ||
| 2025-09-30 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $56.80K derived: sum of 2 quarters · filed 2026-08-14 | $83.44K 10-Q · filed 2025-11-14 | $112.99K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $27.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $54.44K 10-Q · filed 2026-08-14 | $83.99K derived: sum of 3 quarters · filed 2026-08-14 | $118.26K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $26.64K 10-Q · filed 2026-05-15 | $56.19K derived: sum of 2 quarters · filed 2026-05-15 | $90.46K derived: sum of 3 quarters · filed 2026-05-15 | $110.66K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $29.55K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | $63.82K derived: sum of 2 quarters · filed 2026-04-14 | $84.02K derived: sum of 3 quarters · filed 2026-04-14 | $104.16K 10-K · filed 2026-04-14 | ||
| 2024-09-30 | $34.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $54.47K derived: sum of 2 quarters · filed 2025-11-14 | $74.61K 10-Q · filed 2025-11-14 | $94.72K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $20.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | $40.34K 10-Q · filed 2025-08-18 | $0.00 10-Q · filed 2024-08-14 | $60.45K derived: sum of 3 quarters · filed 2025-08-18 | $123.58K derived: sum of 4 quarters · filed 2025-08-18 | |
| 2024-03-31 | $20.14K 10-Q · filed 2024-05-15 | $40.24K derived: sum of 2 quarters · filed 2025-04-15 | $103.37K derived: sum of 3 quarters · filed 2025-04-15 | $82.49K derived: sum of 4 quarters · filed 2025-04-15 | ||
| 2023-12-31 | $20.11K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $83.23K derived: sum of 2 quarters · filed 2025-04-15 | $62.36K derived: sum of 3 quarters · filed 2025-04-15 | $83.25K 10-K · filed 2025-04-15 | ||
| 2023-09-30 | $63.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-15 | $42.25K derived: sum of 2 quarters · filed 2024-11-15 | $63.15K 10-Q · filed 2024-11-15 | $87.97K derived: sum of 4 quarters · filed 2024-11-15 | ||
| 2023-06-30 | -$20.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $18.00 10-Q · filed 2024-08-14 | $41.59K 10-Q · filed 2023-08-16 | $24.84K derived: sum of 3 quarters · filed 2024-08-14 | $46.50K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $20.90K 10-Q · filed 2024-05-15 | $45.72K derived: sum of 2 quarters · filed 2024-05-15 | $67.38K derived: sum of 3 quarters · filed 2024-05-15 | $90.02K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $24.82K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | $46.48K derived: sum of 2 quarters · filed 2024-04-16 | $69.12K derived: sum of 3 quarters · filed 2024-04-16 | $91.43K 10-K · filed 2024-04-16 | ||
| 2022-09-30 | $21.66K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-03-26 | $44.30K derived: sum of 2 quarters · filed 2024-03-26 | $66.61K 10-Q/A · filed 2024-03-26 | $89.40K derived: sum of 4 quarters · filed 2024-03-26 | ||
| 2022-06-30 | $22.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | $44.94K 10-Q · filed 2023-08-16 | $67.74K derived: sum of 3 quarters · filed 2023-08-16 | $90.20K derived: sum of 4 quarters · filed 2023-08-16 | ||
| 2022-03-31 | $22.31K 10-Q · filed 2023-05-09 | $45.10K derived: sum of 2 quarters · filed 2023-05-09 | $67.57K derived: sum of 3 quarters · filed 2023-05-09 | $102.97K derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | $22.79K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $45.26K derived: sum of 2 quarters · filed 2023-03-31 | $80.66K derived: sum of 3 quarters · filed 2023-03-31 | $91.28K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $22.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $57.87K derived: sum of 2 quarters · filed 2022-11-14 | $68.49K 10-Q · filed 2022-11-14 | $128.71K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $35.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $46.02K 10-Q · filed 2022-08-15 | $106.24K derived: sum of 3 quarters · filed 2022-08-15 | $116.55K derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $10.62K 10-Q · filed 2022-05-16 | $70.84K derived: sum of 2 quarters · filed 2022-05-16 | $81.15K derived: sum of 3 quarters · filed 2022-05-16 | $91.13K derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $60.22K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $70.53K derived: sum of 2 quarters · filed 2022-04-06 | $80.51K derived: sum of 3 quarters · filed 2022-04-06 | $90.79K 10-K · filed 2022-04-06 | ||
| 2020-09-30 | $10.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $30.57K 10-Q · filed 2020-11-03 | $30.57K 10-Q · filed 2021-11-15 | -$30.57K 10-Q · filed 2020-11-03 | $103.58K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $9.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $20.26K 10-Q · filed 2021-08-12 | $93.27K derived: sum of 3 quarters · filed 2021-08-12 | $41.02K derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $10.28K 10-Q · filed 2021-05-18 | $83.29K derived: sum of 2 quarters · filed 2021-05-18 | $31.04K derived: sum of 3 quarters · filed 2021-05-18 | $41.43K derived: sum of 4 quarters · filed 2021-05-18 | ||
| 2019-12-31 | $73.01K derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-03-30 | $20.76K derived: sum of 2 quarters · filed 2021-03-30 | $31.15K derived: sum of 3 quarters · filed 2021-03-30 | $41.71K 10-K · filed 2021-03-30 | ||
| 2019-09-30 | -$52.25K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-11-09 | $31.30K 10-Q · filed 2020-11-03 | -$31.30K 10-Q/A · filed 2020-11-09 | $31.30K 10-Q · filed 2019-11-14 | -$21.46K derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $10.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $20.95K 10-Q · filed 2020-08-11 | $30.79K derived: sum of 3 quarters · filed 2020-08-11 | $40.76K derived: sum of 4 quarters · filed 2020-08-11 | ||
| 2019-03-31 | $10.56K 10-Q · filed 2020-05-08 | $20.40K derived: sum of 2 quarters · filed 2020-05-08 | $30.37K derived: sum of 3 quarters · filed 2020-05-08 | |||
| 2018-12-31 | $9.84K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-31 | $19.81K derived: sum of 2 quarters · filed 2020-03-31 | $40.61K 10-K · filed 2020-03-31 | |||
| 2018-09-30 | $9.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $30.77K 10-Q · filed 2019-11-14 | ||||
| 2018-06-30 | $20.80K 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |